About Us
Integrative Therapy Discovery Lab S.r.l. was created from an idea of Prof. Massimo Nabissi, with the participation of the University of Camerino.
ITD Lab is an innovative R&D startup focused on the development of patents for the formulation of phytotherapy and cannabis-based products.
Read More
These products are going through a period of strong growth: phytotherapy-based products recorded an increase of 6.4% and their value reached 2.5 billion euros in the last two years, corresponding to 10% of the turnover of the Italian pharmaceutical market, while cannabis-based products boast 263 million consumers throughout the world for an annual expenditure of 344 billion dollars.
Our main goal is to constantly propose technologically advanced systems to improve the quality of the products and their therapeutic efficacy, as well as to become a global reference in the research and development of phytotherapeutic and cannabinoid products.
At the moment, there are few entrepreneurial initiatives such as ITD Lab capable of addressing the issue of the use of phytotherapics in an in-depth and specific way on the role and effectiveness in various diseases, in particular those of an immune, inflammatory and oncological nature with the aim of validating or developing new therapeutic compositions.
Our main goal is to constantly propose technologically advanced systems to improve the quality of the products and their therapeutic efficacy, as well as to become a global reference in the research and development of phytotherapeutic and cannabinoid products.
At the moment, there are few entrepreneurial initiatives such as ITD Lab capable of addressing the issue of the use of phytotherapics in an in-depth and specific way on the role and effectiveness in various diseases, in particular those of an immune, inflammatory and oncological nature with the aim of validating or developing new therapeutic compositions.
Integrative Therapy Discovery Lab S.r.l. was created from an idea of Prof. Massimo Nabissi, with the participation of the University of Camerino.
ITD Lab is an innovative R&D startup focused on the development of patents for the formulation of phytotherapy and cannabis-based products.
Services
COLLABORATION SERVICE
Third parties service for R&D projects to evaluate the therapeutic efficacy of molecules in the preclinical setting.
PATENT LICENSING
Development and licensing / sale of patents, created through internal research or as a collaboration with third parties.
NEW FORMULATIONS DEVELOPMENT
Development of formulations and trade secrets of specific and selective phytotherapeutic compounds towards a target pathology.
In the articulated market of phytotherapy products, most of those that fill the shelves of supermarkets and drugstores are not medicines, but belong to the categories of food supplements, cosmetics, food or medical devices, each with distinct characteristics and governed by different regulations.
Several studies (ref. Italian Society of Phytotherapy) highlight the blurred outlines of health claims, marketing authorizations and quality controls between medicinal herbs and non-pharmaceutical products, such as food supplements and cosmetics.
One of the services offered by ITD Lab falls within the scope of this issue, namely the validation, using recognized preclinical models, of the potential applications of phytotherapeutic products or food supplements, specifying the possible use with specific health indications.
The services we offer to companies:
Development of validated preclinical protocols and models, useful for identifying specific applications of new phytotherapy-based products and of those already on the market.
Provide to companies producing phytotherapics and food supplements a research service for the biological and functional characterization of their products on the market.
Values
ITD Lab is committed to the creation of a highly efficient and innovative research and development system.
The four values underlying our work:
Improvement of the quality of life for all those who will use the products created with our studies.
Continuous research and innovation.
Constant dialogue and communication with our customers.
Dissemination of information and knowledge on the use of phytoterapy-based products and combined therapies.
Mission
Recently, in the nutritional supplementation and cosmetics field, mild therapeutic indications have spread without a precise definition regarding their biological value. ITD Lab has set itself the goal of identifying new research methodologies and formulations for phytoterapeutic products through the development and validation of preclinical models and the installation of research laboratories equipped with the following technologies:
- in vivo imaging, techniques for studying and visualizing the interactions between living organisms from the anatomical / morphological and molecular point of view;
- high-throughput screening, techniques to quickly test samples for their biological activity;
- 3D cell culture models.
The added value we want to guarantee is the greater therapeutic efficacy of the products made through our studies compared to all the others on the market.
These products will also differ from others because they will provide a greater amount of biological and combination therapy information, as well as guaranteeing greater safety and a multitude of specific uses.
Recently, in the nutritional supplementation and cosmetics field, mild therapeutic indications have spread without a precise definition regarding their biological value. ITD Lab has set itself the goal of identifying new research methodologies and formulations for phytoterapeutic products through the development and validation of preclinical models and the installation of research laboratories equipped with the following technologies:
- in vivo imaging, techniques for studying and visualizing the interactions between living organisms from the anatomical / morphological and molecular point of view;
- high-throughput screening, techniques to quickly test samples for their biological activity;
- 3D cell culture models.
The added value we want to guarantee is the greater therapeutic efficacy of the products made through our studies compared to all the others on the market.
These products will also differ from others because they will provide a greater amount of biological and combination therapy information, as well as guaranteeing greater safety and a multitude of specific uses.
Team
Research & Development
Dr. Massimo Nabissi Ph.D.
CEO & CTO
View Bio
Degree in Biological Sciences in 1992 and a Ph.D. in Molecular Biology in 1996. Since 2017, he is Associate Professor in Technical Sciences of Laboratory of Medicine at the University of Camerino. His research is focused on the pre-clinical studies on oncology, immunology and inflammation field. Since 2009, he studies phytotherapy, with particular regards to phytocannabinodes and molecules isolated from medicinal plants. To date, he published more than 90 scientific publications and book chapters. He is co-author of two international patents.
Dr. Oliviero Marinelli Ph.D.
Scientific collaborator
View Bio
Degree in Pharmaceutical Chemistry and Technology at the University of Camerino. Ph.D. in Molecular Biology and Cellular Biotechnology, University of Camerino. Research fellow in Technical Sciences of Laboratory of Medicine, at the School of Pharmacy, University of Camerino.
Experience in cellular and molecular biology.
Dr. Maria Beatrice Morelli
Researcher
View Bio
Dr. Maria Beatrice Morelli is a researcher in Immunopathology with expertise in cellular and molecular biology, immuno-oncology and phytomedicine at the University of Camerino. In 2010 she got the Phd in immunological Science at the Università La Sapienza in Rome. After that she worked as post-doctoral researcher granted by the Pansteur Institute and Fondazione Veronesi. In 2017, she is a PRIN participant with the project “Physiological neuronal activity in the control of glioma progression and tumor microenvironment”.
Dr.ssa Cristina Aguzzi
ITD Lab PhD student
View Bio
Degree in Pharmaceutical Chemistry and Technology, at the University of Camerino. From November 2020 she is ITD Lab Ph.D. student in Molecular Biology and Cellular Biotechnology.
Experience in cellular and molecular biology.
Dr.ssa Laura Zeppa
ITD Lab PhD student
View Bio
Degree in Pharmaceutical Chemistry and Technology at the University of Camerino. From November 2020 she is ITD Lab Ph.D. student in Molecular Biology and Cellular Biotechnology.
Experience in cellular and molecular biology.
Finance & Strategy
Paolo Salvatori
CFO
View Bio
Degree in Economics and Business from the University of Perugia. In 1995, he obtained the qualification to practice as a Chartered Accountant. Since 1996 he has been a member of the Order of Chartered Accountants and Accounting Experts of Macerata and Camerino. Since 2000, he has been working as an associate of the “BRUZZECHESSE-SALVATORI Professional Association”.
Karina Barcelos
Strategic Consultant
View Bio
Degree in Law from Faculdade de Direito Milton Campos in Nova Lima (MG, Brazil) in 2012. In 2014, she becomes partner of the family company Cedro Construçoes and Empreendimentos Imobiliários Ltda. Being always passionate about innovation and sustainability, since 2019 she supports entrepreneurial initiatives in the field of social impact.
Giorgio Bruzzechesse
Financial Consultant
View Bio
Degree in Economics and Business from the University of Ancona. In 1995 he obtained the qualification to practice as a Chartered Accountant. Since 1996 he has been enrolled in the Order of Chartered Accountants and Accounting Experts of Ancona. Since 2000 he has been working as an associate of the “BRUZZECHESSE-SALVATORI Professional Association”.
Dr. Hadar Ron
Strategic Advisor
View Bio
Dr. Hadar Ron is the founding partner of Israel Healthcare Ventures (IHCV), a fund focused on investing in global and Israeli companies in the field of medical devices, biotechnology, pharmaceutical and medical related IT. She is a physician and attorney by education. Her background includes extensive medical, legal and management experience gained in senior positions in the range of insurance companies, law firms, medical and educational institutions. Dr. Ron’s legal and management expertise includes private equity capital management. She serves as an active chairperson of several Life Science companies, medical malpractice, general and medical insurance and legal practice. Dr. Ron is closely familiar with the field of development of medical products and systems, medical IT and data, with a wide experience being a member of global public and private boards of directors.
Aurelio Serrao
Strategic Advisor
View Bio
Degree in Biological Sciences. During his Ph.D., in order to complete his project, he worked in Boston at the Harvard School of Public Health and at Imperial College in London. He is co-author of 2 patents filed with the US patent office. Since 2016, he is co-founder and CEO of Biovecblok S.r.l..